Mandate

Vinge advises on Fagerberg & Dellby’s acquisition of BIG BAG together with the management of APELNS

January 31, 2011

Vinge acted as legal adviser in connection with Fagerberg & Dellby Fond I AB’s acquisition of BIG BAG Sweden AB together with the management of APELNS Express AB, Leif Karlberg and Claes Cardell, to form a new player in the recycling industry.

The combination of BIG BAG and APELNS creates a strong player in the environmentally sound collection and recycling of construction, industrial and office waste and bulky waste from properties. A total of 99% of the collected waste is recycled, reused or used for combustion purposes thanks to Sweden’s probably most technically advanced automated processing and sorting facility. BIG BAG and APELNS have a combined turnover of approximately SEK 215 million and both have attracted attention as so-called gazelle companies. Fagerberg & Dellby invests in Swedish family-owned companies and is owned by the founders Christina Fagerberg and Ulrika Dellby together with several family business entrepreneurs and pension funds.

Vinge’s team advising Fagerberg & Dellby consisted of partners Malin Leffler and Fabian Ekeblad together with, among others, associates Jonas Johansson, Paul Dali, Emma Lindelöf and Sofia Berg.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025